Spinosad

Allegis Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: May 31, 2023
Approval ID: 8e87bd3b-db25-4e97-bf57-96c875f67ce1
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Spinosad Topical Suspension safely and effectively. See full prescribing information for Spinosad Topical Suspension. Spinosad Topical Suspension Initial U.S. Approval: 2011

Quick Stats

Total Products1

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.